Kinase Suppressor Of Ras 2 (KSR2)
The predicted 829-amino acid protein has a molecular mass of approximately 105 kD. Similar to KSR1 , KSR2 appears to lack the CA1 domain. KSR2 shares 61% amino acid identity with KSR1. Northern blot analysis revealed expression mainly in kidney and brain. Coimmunoprecipitation studies showed that KSR2 interacted with components of the MAPK pathway, including RAF (RAF1), MEK (MAP2K1), and ERK (MAPK3).Cotransfection of KSR2 with COT in HEK-293T cells lead to reduced COT-mediated ERK activation in a dose-dependent manner; however, RAF-mediated ERK activation was not significantly attenuated by coexpression with KSR2, suggesting that the effect is selective. Luciferase reporter assays showed that KSR2 inhibited COT-induced NF-kappa-B activation but did not inhibit IKKB-mediated NF-kappa-B activation.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Kinase Suppressor Of Ras 2 (KSR2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Kinase Suppressor Of Ras 2 (KSR2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Kinase Suppressor Of Ras 2 (KSR2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Kinase Suppressor Of Ras 2 (KSR2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Kinase Suppressor Of Ras 2 (KSR2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Kinase Suppressor Of Ras 2 (KSR2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Kinase Suppressor Of Ras 2 (KSR2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Kinase Suppressor Of Ras 2 (KSR2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Kinase Suppressor Of Ras 2 (KSR2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Kinase Suppressor Of Ras 2 (KSR2) ELISA Kit Customized Service Offer
  1. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  2. "The finished DNA sequence of human chromosome 12." Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract]
  3. "Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling."J. Biol. Chem. 278:47089-47097(2003) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation."Biochem. Biophys. Res. Commun. 334:1214-1218(2005) [PubMed] [Europe PMC] [Abstract]
  6. "A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK."Nature 472:366-369(2011) [PubMed] [Europe PMC] [Abstract]
  7. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]